SystImmune Inc. (SystImmune), a clinical-stage biotechnology company, today announced positive topline results from the BL-B01D1-301 trial. The trial has met one of the dual primary endpoints ...
Hartgraves & the Adventure in Time! FORT WORTH, TX / ACCESS Newswire / October 19, 2025 / Author Pete Hartgraves is ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈